Citations for
1TES
The Role of Testin in Human Cancers
Popiel A, Kobierzycki C, Dzięgiel P.
Pathol Oncol Res. Oct;25(4):1279-1284. doi: 10.1007/s12253-018-0488-3. Epub 2018 Oct 25. 2019
2TES
Testin protects against cardiac hypertrophy by targeting a calcineurin-dependent signalling pathway.
Gao L, Liu Y, Guo S, Xiao L, Liang C, Wang X.
J Cell Mol Med. Jan;23(1):328-339. doi: 10.1111/jcmm.13934. Epub 2018 Nov 22. 2019
3TES
The PET and LIM1-2 domains of testin contribute to intramolecular and homodimeric interactions
Sala S, Catillon M, Hadzic E, Schaffner-Reckinger E, Van Troys M, Ampe C.
PLoS One. May 18;12(5):e0177879. doi: 10.1371/journal.pone.0177879. 2017
4TES
TESTIN Induces Rapid Death and Suppresses Proliferation in Childhood B Acute Lymphoblastic Leukaemia Cells
Weeks RJ, Ludgate JL, LeMée G, Morison IM.
PLoS One. Mar 17;11(3):e0151341. doi: 10.1371/journal.pone.0151341. 2016
5TES
TESTIN was commonly hypermethylated and involved in the epithelial-mesenchymal transition of endometrial cancer
Dong R, Pu H, Wang Y, Yu J, Lian K, Mao C.
APMIS May;123(5):394-400. doi: 10.1111/apm.12361. Epub 2015 Feb 27 2015
6TES
Comparative gene expression analysis between coronary arteries and internal mammary arteries identifies a role for the TES gene in endothelial cell functions relevant to coronary artery disease.
Archacki SR, Angheloiu G, Moravec CS, Liu H, Topol EJ, Wang QK.
Hum Mol Genet 21(6):1364-73. Epub 2011 Dec 12. 2012
7CASR, TES
Testin, a novel binding partner of the calcium-sensing receptor, enhances receptor-mediated Rho-kinase signalling.
Magno AL, Ingley E, Brown SJ, Conigrave AD, Ratajczak T, Ward BK.
Biochem Biophys Res Commun 412(4):584-9. Epub 2011 Aug 6. 2011
8NR5A1, SOX9, SRY, TES
Failure of SOX9 regulation in 46XY disorders of sex development with SRY, SOX9 and SF1 mutations.
Knower KC, Kelly S, Ludbrook LM, Bagheri-Fam S, Sim H, Bernard P, Sekido R, Lovell-Badge R, Harley VR.
PLoS One 6(3):e17751. doi: 10.1371/journal.pone.0017751. 2011
9TES
Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene.
Ma H, Weng D, Chen Y, Huang W, Pan K, Wang H, Sun J, Wang Q, Zhou Z, Wang H, Xia J.
Mol Cancer 9:190. 2010
10TES
Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemia.
Weeks RJ, Kees UR, Song S, Morison IM.
Mol Cancer 9:163. 2010
11TES
Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
Gunduz E, Gunduz M, Beder L, Nagatsuka H, Fukushima K, Sutcu R, Delibas N, Yamanaka N, Shimizu K, Nagai N.
Arch Otolaryngol Head Neck Surg 135(3):254-60. 2009
12TES
LIM domain protein TES changes its conformational states in different cellular compartments.
Zhong Y, Zhu J, Wang Y, Zhou J, Ren K, Ding X, Zhang J.
Mol Cell Biochem 320(1-2):85-92. Epub 2008 Aug 12. 2009
13ENAH, TES
Tes, a specific Mena interacting partner, breaks the rules for EVH1 binding.
Boëda B, Briggs DC, Higgins T, Garvalov BK, Fadden AJ, McDonald NQ, Way M.
Mol Cell 28(6):1071-82. 2007
14EVL, SPTAN1, TES
AlphaII-spectrin interacts with Tes and EVL, two actin-binding proteins located at cell contacts.
Rotter B, Bournier O, Nicolas G, Dhermy D, Lecomte MC.
Biochem J 388(Pt 2):631-8. 2005
15TES
Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene.
Chêne L, Giroud C, Desgrandchamps F, Boccon-Gibod L, Cussenot O, Berthon P, Latil A.
Int J Cancer 111(5):798-804. 2004
16CAV1, CAV2, FRA7G, TES
Candidate tumor suppressor genes at FRA7G are coamplified with MET and do not suppress malignancy in a gastric cancer
Han SY, Druck T, Huebner K.
Genomics 81(2):105-7. 2003
17TES
The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein.
Tobias ES, Hurlstone AF, MacKenzie E, McFarlane R, Black DM.
Oncogene 20(22):2844-53. 2001
18CAPZA2, FRA7G, TES
Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2.
Tatarelli C, Linnenbach A, Mimori K, Croce CM.
Genomics 68(1):1-12. 2000